ARCHIVES

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

Agreement Reached On Most CCOP Issues; First RFA To Be Out March, Awards To Be Made In Fiscal 1983

January 22, 1982

Foundation Supports Chicago Researchers

September 10, 1993

An Early Look At How NCI Plans To Spend Its Money In 1980

July 7, 1978

Pittsburgh, Norris Win Bristol-Myers Unrestricted Grants

April 19, 1991

Orders Still Accepted For 20th Anniversary Special Publication

July 19, 1991